Thymus cancer treatment with chemotherapy

Chemotherapy has been found effective in treating thymus cancer as a primary treatment or in advanced stages. It is also effective as a component of adjuvant therapy to prevent possible relapses, particularly in cases with multiple distant metastases. A previous comprehensive evaluation of the patient’s general health status and disease history is required before the beginning of full-scale chemotherapy use. Often, chemotherapy decreases the size of the primary tumor and makes it applicable for further surgery. Nowadays, oncologists might choose from a broad range of different medications for chemotherapy, including cisplatin, doxorubicin, cyclophosphamide, carboplatin, etoposide, and many others. Depending on the patient’s current physical state, thymus cancer features, and many other factors, medical practitioners might choose a single-drug therapy or prescribe a combination of those medications. A single chemotherapy treatment session might take 2-4 hours, as most medications deliver very slowly to prevent possible adverse effects via intravenous drips. Also, patients got between 2 to 10 weeks to renew after a chemotherapy session. A single course contains 2 to 10 treatment sessions, and the overall number of sessions depends greatly on the severity of a specific case.